logo
MRC Global Reports Full Year and Fourth Quarter 2024 Results

MRC Global Reports Full Year and Fourth Quarter 2024 Results

HOUSTON, March 14, 2025 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC) today reported full year and fourth quarter 2024 results.
Full Year 2024 Financial Highlights:
● Operating cash flows from continuing operations of $268 million, highest since 2015
● Sales of $3,011 million
● Net income from continuing operations of $78 million
● Adjusted EBITDA of $202 million, 6.7% of sales
● Gross profit, as a percentage of sales, of 20.6%
● Adjusted Gross Profit, as a percentage of sales, of 21.9% and the third consecutive year above 21%
● Net Debt of $324 million, a 1.6x net debt leverage ratio
Fourth Quarter 2024 Financial Highlights:
● Operating cash flows from continuing operations of $73 million
● Sales of $664 million
● Net loss from continuing operations of ($1) million
● Adjusted EBITDA of $32 million, or 4.8% of sales
● Gross profit, as a percentage of sales, of 20.3%
● Adjusted Gross Profit, as a percentage of sales, of 22.0%
● Working capital, as a percentage of sales, of 11.2%, a record low for the company
Rob Saltiel, MRC Global's President and Chief Executive Officer, commented, 'We are optimistic about our business outlook for 2025 due to the rebound of our gas utilities business, the return of inflation to our product pricing, the growth of U.S. natural gas infrastructure investment and our penetration into chemicals, mining and data center markets. We are also very excited to announce today our new IMTEC joint venture which simplifies the development of smart meters for our gas utilities customers. We anticipate growth in all three business sectors in 2025 and for revenue to be up low to high-single digits. In addition, we expect to generate at least $100 million in cash from operations, achieve our target net debt leverage ratio of 1.5x by year end and to have ample cash to begin execution of our recently announced $125 million share buyback authorization.'
Mr. Saltiel continued, 'Looking back on 2024, I am very pleased with the successful execution of several strategic actions that simplified and strengthened our balance sheet while de-risking our future financing needs. We achieved average annual Adjusted Gross Profit margins that exceeded 21% for the third year in a row. We generated $268 million of operating cash flow from continuing operations, aided by significant improvements in our working capital efficiency, despite a slow finish to the year.'
The company previously delayed the release of its financial results to allow additional time to complete year-end procedures specifically related to inventory cycle counts. The completion of these procedures resulted in no adjustments to either the income statement or balance sheet in 2024 or any restatement of prior periods.
Consistent with the previously announced sale of the Canada business, Canada results are reflected in discontinued operations for all periods presented. Canada discontinued operational losses including operating losses and the loss incurred on the sale, were ($22) million for the fourth quarter of 2024 and ($23) million for the year ended 2024. The sale is scheduled to close this month.
Adjusted Net Income (Loss) from continuing operations, Adjusted Net (Loss) Income Attributable to Common Stockholders, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Gross Profit, Adjusted Gross Profit margin, Net Debt, Net Debt Leverage Ratio and Adjusted selling, general and administrative (SG&A) expense are all non-GAAP measures. Please refer to the reconciliation of each of these measures to the nearest GAAP measure in this release.
Net loss from continuing operations for the fourth quarter of 2024 was ($1) million, or ($0.14) per diluted share, as compared to net income from continuing operations of $22 million, or $0.19 per diluted share, in the fourth quarter of 2023. Net income from continuing operations for the full years 2024 and 2023 was $78 million, or $0.57 per diluted share, and $115 million, or $1.06 per diluted share, respectively. Adjusted net income from continuing operations for the fourth quarter of 2024 and the fourth quarter of 2023 was $4 million, and $27 million, respectively. Adjusted net income from continuing operations for the full year 2024 and 2023 was $86 million and $122 million, respectively.
MRC Global's fourth quarter 2024 gross profit was $135 million, or 20.3% of sales, as compared to gross profit of $149 million, or 20.1% of sales, in the fourth quarter of 2023. Gross profit for the fourth quarter of 2024 and 2023 includes expense of $1 million and $5 million for the last-in, first out (LIFO) method of inventory cost accounting, respectively. Adjusted Gross Profit, as a percentage of sales, which excludes these items, as well as others, was 22.0% and 22.2% in the fourth quarter of 2024 and 2023, respectively.
SG&A expenses were $123 million, or 18.5% of sales, for the fourth quarter of 2024 as compared to $121 million, or 16.4% of sales, for the same period of 2023. Adjusted SG&A expense for the fourth quarter of 2024 and 2023 was $119 million, or 17.9% of sales, and $120 million, or 16.2% of sales, respectively.
For the three months ended December 31, 2024, income tax expense was $4 million with an effective rate of 133%, which was primarily impacted by foreign currency gains on debt restructuring and low pretax income for the quarter. For the three months ended December 31, 2023, income tax expense was $2 million with an effective rate of 8% which was favorably impacted by a net reduction in a foreign valuation allowance provision. Annual effective tax rates for 2024 and 2023 were 26% and 25%, respectively. Our rates generally differ from the U.S. federal statutory rate of 21% as a result of state income taxes, non-deductible expenses and differing foreign income tax rates.
Adjusted EBITDA was $32 million in the fourth quarter of 2024 as compared to $49 million for the same period in 2023. Please refer to the reconciliation of non-GAAP measures (Adjusted EBITDA) to GAAP measures (net income (loss) from continuing operations) in this release.
Sales
The company's sales were $664 million for the fourth quarter of 2024, 10% lower than the fourth quarter of 2023 and a 14% decrease from the third quarter of 2024. As compared to the fourth quarter of 2023, the decrease was driven by the Downstream, Industrial and Energy Transition (DIET) sector followed by the Production & Transmission Infrastructure (PTI) sector. The sequential sales decline was across all sectors.
Sales by Segment
U.S. sales in the fourth quarter of 2024 were $542 million, a $91 million, or 14%, decrease from the same quarter in 2023. Gas Utilities sector sales were consistent with the prior year. DIET sector sales decreased by $48 million, or 25%, due to the conclusion of several projects and lower turnaround spending. PTI sector sales decreased $43 million, or 23%, due to lower customer activity and fewer projects.
Sequentially, U.S. sales in the fourth quarter of 2024, as compared to the third quarter of 2024, were down $102 million, or 16%. The Gas Utilities sector experienced a $41 million, or 14%, decline primarily from typical seasonal buying patterns and deferred spending. PTI sector sales were down $34 million, or 19%, due to lower year-end customer activity and seasonality, and non-repeating projects. The DIET sector was down $27 million, or 16%, due to the conclusion of various projects and lower turnaround activity.
International sales in the fourth quarter of 2024 were $122 million, up $15 million, or 14%, from the same period in 2023 as all sectors experienced growth. The PTI sector increase was driven primarily by multiple projects in Norway. The DIET sector increase was driven primarily by projects in the Middle East and Asia.
Sequentially, International sales in the fourth quarter of 2024, as compared to the third quarter of 2024, were down $5 million, or 4%. The DIET sector decrease was due to lower turnaround activity and timing of project deliveries in Europe and the Nordics. The PTI sector decrease was driven by the timing of project deliveries in Australia, Asia and the U.K.
Sales by Sector
Gas Utilities sector sales, which are primarily U.S based, were $253 million in the fourth quarter of 2024, or 38% of total sales, unchanged from the fourth quarter of 2023.
Sequentially, Gas Utilities sector sales in the fourth quarter of 2024, as compared to the third quarter of 2024, declined $40 million, or 14%.
DIET sector sales in the fourth quarter of 2024 were $208 million, or 31% of total sales, a decrease of $46 million, or 18%, from the fourth quarter of 2023 driven by the U.S. segment.
Sequentially, DIET sector sales in the fourth quarter of 2024, as compared to the prior quarter, decreased $31 million, or 13%, driven by the U.S. segment.
PTI sector sales in the fourth quarter of 2024 were $203 million, or 31% of total sales, a decreased of $30 million, or 13%, from the fourth quarter of 2023 driven by the U.S. segment.
Sequentially, PTI sector sales in the fourth quarter of 2024, as compared to the previous quarter, decreased $36 million, or 15%, driven by the U.S. segment.
Balance Sheet and Cash Flow
As of December 31, 2024, the company's cash balance was $63 million, long-term debt (including current portion) was $387 million, and Net Debt was $324 million. Cash provided by operations from continuing operations was $73 million in the fourth quarter of 2024 resulting in $268 million of cash provided by operations from continuing operations for the full year 2024. Availability under the company's ABL facility was $460 million, and liquidity was $523 million as of December 31, 2024. Please refer to the reconciliation of non-GAAP (Net Debt) to GAAP measures (long-term debt, net) in this release.
Conference Call
The company will hold a conference call to discuss its fourth quarter and full year 2024 results at 10:00 a.m. Eastern Time (9:00 a.m. Central Time) on March 14, 2025. To participate in the call, please dial 201-689-8261 and ask for the MRC Global conference call. To access the conference call, live over the Internet, please log onto the web at www.mrcglobal.com and go to the 'Investors' page of the company's website. A replay will be available through March 28, 2025, and can be accessed by dialing 201-612-7415 and using passcode 13752336#. Also, an archive of the webcast will be available shortly after the call at www.mrcglobal.com for 90 days.
About MRC Global Inc.
Headquartered in Houston, Texas, MRC Global (NYSE: MRC) is the leading global distributor of pipe, valves, fittings (PVF) and other infrastructure products and services to diversified end-markets including the gas utilities, downstream, industrial and energy transition, and production and transmission infrastructure sectors. With over 100 years of experience, MRC Global has provided customers with innovative supply chain solutions, technical product expertise and a robust digital platform from a worldwide network of approximately 200 locations including valve and engineering centers. The company's unmatched quality assurance program offers approximately 200,000 SKUs from over 7,100 suppliers, simplifying the supply chain for over 8,300 customers. Find out more at www.mrcglobal.com
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Words such as 'will', 'expect', 'expected', 'intend', 'believes' and similar expressions are intended to identify forward-looking statements.
Statements about the company's business, including its strategy, its industry, the company's future profitability, the company's guidance on its sales, adjusted EBITDA, tax rate, capital expenditures, achieving cost savings and cash flow, debt reduction, liquidity, growth in the company's various markets and the company's expectations, beliefs, plans, strategies, objectives, prospects and assumptions are not guarantees of future performance. These statements are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, most of which are difficult to predict and many of which are beyond MRC Global's control, including the factors described in the company's SEC filings that may cause the company's actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements.
These risks and uncertainties include (among others) decreases in capital and other expenditure levels in the industries that the company serves; U.S. and international general economic conditions; geopolitical events; decreases in oil and natural gas prices; unexpected supply shortages; loss of third-party transportation providers; cost increases by the company ' s suppliers and transportation providers; increases in steel prices, which the company may be unable to pass along to its customers which could significantly lower the company ' s profit; the company ' s lack of long-term contracts with most of its suppliers; suppliers ' price reductions of products that the company sells, which could cause the value of its inventory to decline; decreases in steel prices, which could significantly lower the company ' s profit; a decline in demand for certain of the products the company distributes if tariffs and duties on these products are imposed or lifted; holding more inventory than can be sold in a commercial time frame; significant substitution of renewables and low-carbon fuels for oil and gas, impacting demand for the company ' s products; risks related to adverse weather events or natural disasters; environmental, health and safety laws and regulations and the interpretation or implementation thereof; changes in the company ' s customer and product mix; the risk that manufacturers of the products that the company distributes will sell a substantial amount of goods directly to end users in the industry sectors that the company serves; failure to operate the company ' s business in an efficient or optimized manner; the company ' s ability to compete successfully with other companies; the company ' s lack of long-term contracts with many of its customers and the company ' s lack of contracts with customers that require minimum purchase volumes; inability to attract and retain employees or the potential loss of key personnel; adverse health events, such as a pandemic; interruption in the proper functioning of the company ' s information systems; the occurrence of cybersecurity incidents; risks related to the company ' s customers ' creditworthiness; the success of acquisition strategies; the potential adverse effects associated with integrating acquisitions and whether these acquisitions will yield their intended benefits; impairment of the company ' s goodwill or other intangible assets; adverse changes in political or economic conditions in the countries in which the company operates; the company ' s significant indebtedness; the dependence on the company ' s subsidiaries for cash to meet parent company obligations; changes in the company ' s credit profile; potential inability to obtain necessary capital; the potential share price volatility and costs incurred in response to any shareholder activism campaigns; the sufficiency of the company ' s insurance policies to cover losses, including liabilities arising from litigation; product liability claims against the company; pending or future asbestos-related claims against the company; exposure to U.S. and international laws and regulations, regulating corruption, limiting imports or exports or imposing economic sanctions; risks relating to ongoing evaluations of internal controls required by Section 404 of the Sarbanes-Oxley Act and a material weakness related to our inventory cycle count control if it remains unremediated; and risks related to changing laws and regulations including trade policies and tariffs.
For a discussion of key risk factors, please see the risk factors disclosed in the company's SEC filings, which are available on the SEC's website at www.sec.gov and on the company's website, www.mrcglobal.com. MRC Global's filings and other important information are also available on the 'Investors' page of the company's website at www.mrcglobal.com.
Undue reliance should not be placed on the company's forward-looking statements. Although forward-looking statements reflect the company's good faith beliefs, reliance should not be placed on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which may cause the company's actual results, performance or achievements or future events to differ materially from anticipated future results, performance or achievements or future events expressed or implied by such forward-looking statements. The company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise, except to the extent required by law.
Contact:
Monica Broughton
VP, Investor Relations & Treasury
MRC Global Inc.
[email protected]
832-308-2847
MRC Global Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(in millions)
December 31, December 31,
2024 2023
Assets
Current assets:
Cash $ 63 $ 131
Accounts receivable, net 378 410
Inventories, net 415 511
Other current assets 29 34
Current assets of discontinued operations 36 69
Total current assets 921 1,155
Long-term assets:
Operating lease assets 170 196
Property, plant and equipment, net 89 77
Other assets 37 21
Noncurrent assets of discontinued operations - 10
Intangible assets:
Goodwill, net 264 264
Other intangible assets, net 143 163
Total assets $ 1,624 $ 1,886
Liabilities and stockholders' equity
Current liabilities:
Trade accounts payable $ 329 $ 340
Accrued expenses and other current liabilities 124 100
Operating lease liabilities 31 32
Current portion of debt obligations 3 292
Current liabilities of discontinued operations 21 19
Total current liabilities 508 783
Long-term obligations:
Long-term debt 384 9
Operating lease liabilities 153 179
Deferred income taxes 35 45
Other liabilities 28 20
Noncurrent liabilities of discontinued operations - 7
Commitments and contingencies
6.5% Series A Convertible Perpetual Preferred Stock, $0.01 par value; authorized no and 363,000 shares, respectively; no and 363,000 shares issued and outstanding, respectively - 355
Stockholders' equity:
Common stock, $0.01 par value per share: 500 million shares authorized, 109,460,293 and 108,531,564 issued, respectively 1 1
Additional paid-in capital 1,779 1,768
Retained deficit (652) (678)
Treasury stock at cost: 24,216,330 shares (375) (375)
Accumulated other comprehensive loss (237) (228)
Total stockholders' equity 516 488
Total liabilities and stockholders' equity $ 1,624 $ 1,886
MRC Global Inc.
Condensed Consolidated Statements of Operations (Unaudited)
(in millions, except per share amounts)
Three Months Ended Year Ended
December 31, December 31, December 31, December 31,
2024 2023 2024 2023
Sales $ 664 $ 740 $ 3,011 $ 3,266
Cost of sales 529 591 2,391 2,596
Gross profit 135 149 620 670
Selling, general and administrative expenses 123 121 485 482
Operating income 12 28 135 188
Other (expense) income:
Interest expense (7) (6) (26) (32)
Other, net (2) 2 (4) (2)
Income from continuing operations before income taxes 3 24 105 154
Income tax expense from continuing operations 4 2 27 39
Net (loss) income from continuing operations (1) 22 78 115
Loss from discontinued operations, net of tax (22) (1) (23) (1)
Net (loss) income (23) 21 55 114
Series A preferred stock dividends 2 6 20 24
Loss on repurchase and retirement of preferred stock 9 - 9 -
Net (loss) income attributable to common stockholders $ (34) $ 15 $ 26 $ 90
Basic (loss) earnings per common share:
(Loss) income from continued operations $ (0.14) $ 0.19 $ 0.58 $ 1.08
Loss from discontinued operations (0.26) (0.01) (0.27) (0.01)
Basic (loss) earnings per common share $ (0.40) $ 0.18 $ 0.31 $ 1.07
Diluted (loss) earnings per common share:
(Loss) income from continued operations $ (0.14) $ 0.19 $ 0.57 $ 1.06
Loss from discontinued operations (0.26) (0.01) (0.27) (0.01)
Diluted (loss) earnings per common share $ (0.40) $ 0.18 $ 0.30 $ 1.05
Weighted-average common shares, basic 85.2 84.3 85.1 84.2
Weighted-average common shares, diluted 85.2 85.9 86.6 85.5
MRC Global Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in millions)
Year Ended
December 31, December 31,
2024 2023
Operating activities
Net income from continuing operations $ 78 $ 115
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Depreciation and amortization 21 19
Amortization of intangibles 19 21
Equity-based compensation expense 16 14
Deferred income tax benefit (8) (7)
(Decrease) increase in LIFO reserve (2) 2
Foreign currency losses 5 3
Other non-cash items 7 3
Changes in operating assets and liabilities:
Accounts receivable 25 57
Inventories 90 15
Other current assets - (3)
Accounts payable (10) (47)
Accrued expenses and other current liabilities 27 (15)
Operating cash flows from continuing operations 268 177
Operating cash flows from discontinued operations 8 4
Net cash provided by operating activities 276 181
Investing activities
Purchases of property, plant and equipment (28) (14)
Proceeds from the disposition of property, plant and equipment - 1
Other investing activities 1 -
Investing cash flows from continuing operations (27) (13)
Investing cash flows from discontinued operations — (1)
Net cash used in investing activities (27) (14)
Financing activities
Payments on revolving credit facilities (449) (882)
Proceeds from revolving credit facilities 484 847
Payments on debt obligations (295) (3)
Proceeds from term loan 348 -
Debt issuance costs paid (7) (1)
Repurchase of preferred stock (365) -
Dividends paid on preferred stock (23) (24)
Repurchases of shares to satisfy tax withholdings (5) (4)
Other financing activities (2) -
Financing cash flows from continuing operations (314) (67)
Financing cash flows from discontinued operations — —
Net cash used in financing activities (314) (67)
(Decrease) increase in cash (65) 100
Effect of foreign exchange rate on cash (3) (1)
Cash beginning of year 131 32
Cash end of year $ 63 $ 131
MRC Global Inc.
Supplemental Sales Information (Unaudited)
(in millions)
Disaggregated Sales by Segment and Sector
Three Months Ended
December 31,
U.S. International Total
2024
Gas Utilities $ 252 $ 1 $ 253
DIET 143 65 208
PTI 147 56 203
$ 542 $ 122 $ 664
2023
Gas Utilities $ 252 $ 1 $ 253
DIET 191 63 254
PTI 190 43 233
$ 633 $ 107 $ 740
Year Ended
December 31,
U.S. International Total
2024
Gas Utilities $ 1,097 $ 1 $ 1,098
DIET 703 267 970
PTI 730 213 943
$ 2,530 $ 481 $ 3,011
2023
Gas Utilities $ 1,190 $ 3 $ 1,193
DIET 790 250 1,040
PTI 865 168 1,033
$ 2,845 $ 421 $ 3,266
MRC Global Inc.
Supplemental Information (Unaudited)
Reconciliation of Gross Profit to Adjusted Gross Profit (a non-GAAP measure)
(in millions)
Three Months Ended
December 31, Percentage December 31, Percentage
2024 of Revenue* 2023 of Revenue*
Gross profit, as reported $ 135 20.3 % $ 149 20.1 %
Depreciation and amortization 5 0.8 % 4 0.5 %
Amortization of intangibles 4 0.6 % 6 0.8 %
Increase in LIFO reserve 1 0.2 % 5 0.7 %
Transaction costs 1 0.2 % - 0.0 %
Adjusted Gross Profit $ 146 22.0 % $ 164 22.2 %
Year Ended
December 31, Percentage December 31, Percentage
2024 of Revenue* 2023 of Revenue
Gross profit, as reported $ 620 20.6 % $ 670 20.5 %
Depreciation and amortization 21 0.7 % 19 0.6 %
Amortization of intangibles 19 0.6 % 21 0.6 %
(Decrease) increase in LIFO reserve (2) (0.1)% 2 0.1 %
Transaction costs 1 0.0 % - 0.0 %
Adjusted Gross Profit $ 659 21.9 % $ 712 21.8 %
Notes to above:
* Does not foot due to rounding
The company defines Adjusted Gross Profit as sales, less cost of sales, plus depreciation and amortization, plus amortization of intangibles, plus inventory-related charges incremental to normal operations, plus transaction costs associated with acquisitions and plus or minus the impact of its LIFO inventory costing methodology. The company presents Adjusted Gross Profit because the company believes it is a useful indicator of the company's operating performance without regard to items, such as amortization of intangibles, that can vary substantially from company to company depending upon the nature and extent of acquisitions of which they have been involved. Similarly, the impact of the LIFO inventory costing method can cause results to vary substantially from company to company depending upon whether they elect to utilize LIFO and depending upon which method they may elect. The company uses Adjusted Gross Profit as a key performance indicator in managing its business. The company believes that gross profit is the financial measure calculated and presented in accordance with U.S. Generally Accepted Accounting Principles that is most directly comparable to Adjusted Gross Profit.
Notes to above:
(1) Employee severance and restructuring charges (pre-tax) in both our U.S. and International segments.
(2) Charge (pre-tax) associated with a facility closure in our International segment.
(3) Charge (pre-tax) for a customer settlement in our U.S. segment.
The company defines adjusted selling, general and administrative (SG&A) expenses as SG&A, less severance and restructuring expenses and other unusual items. The company presents adjusted SG&A because the company believes it is a useful indicator of the company's operating performance. Among other things, adjusted SG&A measures the company's operating performance without regard to certain non-recurring, non-cash or transaction-related expenses. The company uses adjusted SG&A as a key performance indicator in managing its business. The company believes that SG&A is the financial measure calculated and presented in accordance with U.S. Generally Accepted Accounting Principles that is most directly comparable to adjusted SG&A.
Notes to above:
(1) Charge (pre-tax) associated with a facility closure in our International segment.
(2) Employee severance and restructuring charges (pre-tax) in both our U.S. and International segments.
(3) Charges (pre-tax) recorded in SG&A.
(4) Charge (pre-tax) for a customer settlement in our U.S. segment.
(5) Charge (pre-tax) for an asset disposal in our International segment.
The company defines adjusted EBITDA as net income (loss) plus the loss from discontinued operations, net of tax, plus interest, income taxes, depreciation and amortization, amortization of intangibles, and certain other expenses, including non-cash expenses, (such as equity-based compensation, severance and restructuring, changes in the fair value of derivative instruments and asset impairments, including inventory) and plus or minus the impact of its LIFO inventory costing methodology. The company presents adjusted EBITDA because the company believes adjusted EBITDA is a useful indicator of the company's operating performance. Among other things, adjusted EBITDA measures the company's operating performance without regard to certain non-recurring, non-cash or transaction-related expenses. adjusted EBITDA, however, does not represent and should not be considered as an alternative to net income (loss), cash flow from operations or any other measure of financial performance calculated and presented in accordance with GAAP. Because adjusted EBITDA does not account for certain expenses, its utility as a measure of the company's operating performance has material limitations. Because of these limitations, the company does not view adjusted EBITDA in isolation or as a primary performance measure and also uses other measures, such as net income and sales, to measure operating performance. See the company's Annual Report filed on Form 10-K for a more thorough discussion of the use of adjusted EBITDA.
Notes to above:
(1) An after-tax charge associated with a facility closure in our International segment.
(2) An after-tax charge for severance and restructuring charges in both our U.S. and International segments.
(3) An after-tax charge for an asset disposal in our International segment.
(4) An after-tax charge for a customer settlement in our U.S. segment.
The company defines adjusted net income from continuing operations (a non-GAAP measure) as net (loss) income plus the loss from discontinued operations, net of tax, plus or minus the after-tax impact of items deemed non-standard and plus or minus the after-tax impact of its LIFO inventory costing methodology. The impact of the LIFO inventory costing methodology can cause results to vary substantially from company to company depending upon whether they elect to utilize LIFO and depending upon which method they may elect. After-tax impacts were determined using the company's U.S. blended statutory rate. The company presents adjusted net income from continuing operations because the company believes it provides useful comparisons of the company's operating results to other companies, including those companies with whom we compete in the distribution of pipe, valves and fittings to the energy industry, without regard to the irregular variations from certain restructuring events not indicative of the on-going business. The company believes that net (loss) income is the financial measure calculated and presented in accordance with U.S. Generally Accepted Accounting Principles that is most directly compared to adjusted net income from continuing operations.
MRC Global Inc.
Supplemental Information (Unaudited)
Reconciliation of Net (Loss) Income Attributable to Common Stockholders to
Adjusted Net (Loss) Income Attributable to Common Stockholders (a non-GAAP measure)
(in millions, except per share amounts)
December 31, 2024
Three Months Ended Year Ended
Amount Per Share* Amount Per Share*
Net (loss) income attributable to common stockholders $ (34) $ (0.40) $ 26 $ 0.30
Loss from discontinued operations, net of tax 22 0.26 23 0.27
Transaction costs, net of tax 1 0.01 1 0.01
Facility closures, net of tax (1) - - 1 0.01
Severance and restructuring, net of tax (2) 2 0.02 2 0.02
Non-recurring IT related professional fees, net of tax 1 0.01 1 0.01
Asset disposal, net of tax (3) - - 1 0.01
Non-recurring other legal and consulting costs, net of tax 1 0.01 1 0.01
Activism response legal and consulting costs, net of tax - - 3 0.03
Decrease in LIFO reserve, net of tax - - (2) (0.02)
Adjusted Net (Loss) Income Attributable to Common Stockholders $ (7) $ (0.08) $ 57 $ 0.66
December 31, 2023
Three Months Ended Year Ended
Amount Per Share* Amount Per Share*
Net income attributable to common stockholders $ 15 $ 0.18 $ 90 $ 1.05
Loss from discontinued operations, net of tax 1 0.01 1 0.01
Non-recurring IT related professional fees, net of tax - - 1 0.01
Asset disposal, net of tax (3) - - 1 0.01
Customer settlement, net of tax (4) - - 2 0.02
Activism response legal and consulting costs, net of tax 1 0.01 1 0.01
Increase in LIFO reserve, net of tax 4 0.05 2 0.02
Adjusted Net Income Attributable to Common Stockholders $ 21 $ 0.24 $ 98 $ 1.15
Notes to above:
*Does not foot due to rounding
(1) An after-tax charge associated with a facility closure in our International segment.
(2) An after-tax charge for severance and restructuring charges in both our U.S. and International segments.
(3) An after-tax charge for an asset disposal in our International segment.
(4) An after-tax charge for a customer settlement in our U.S. segment.
The company defines adjusted net income (loss) attributable to common stockholders (a non-GAAP measure) as net income (loss) attributable to common stockholders plus the loss from discontinued operations, net of tax, plus or minus the after-tax impact of items deemed non-standard and plus or minus the after-tax impact of its LIFO inventory costing methodology. The impact of the LIFO inventory costing methodology can cause results to vary substantially from company to company depending upon whether they elect to utilize LIFO and depending upon which method they may elect. After-tax impacts were determined using the company's U.S. blended statutory rate. The company presents adjusted net income (loss) attributable to common stockholders and related per share amounts because the company believes it provides useful comparisons of the company's operating results to other companies, including those companies with whom we compete in the distribution of pipe, valves and fittings to the energy industry, without regard to the irregular variations from certain restructuring events not indicative of the on-going business. The company believes that net income (loss) attributable to common stockholders is the financial measure calculated and presented in accordance with U.S. Generally Accepted Accounting Principles that is most directly compared to adjusted net income (loss) attributable to common stockholders.
MRC Global Inc.
Supplemental Information (Unaudited)
Reconciliation of Long-term Debt to
Net Debt (a non-GAAP measure) and the Net Debt Leverage Ratio Calculation
(in millions)
December 31,
2024
Long-term debt $ 384
Plus: current portion of debt obligations 3
Total debt 387
Less: cash 63
Net Debt $ 324
Net Debt $ 324
Trailing twelve months adjusted EBITDA 202
Net debt leverage ratio 1.6 x
Net Debt and related leverage metrics may be considered non-GAAP measures. The company defines Net Debt as long-term debt, including current portion, minus cash. The company defines net debt leverage ratio as Net Debt divided by trailing twelve months adjusted EBITDA. The company believes Net Debt is an indicator of the extent to which the company's outstanding debt obligations could be satisfied by cash on hand and a useful metric for investors to evaluate the company's leverage position. The company believes the net debt leverage ratio is a commonly used metric that management and investors use to assess the borrowing capacity of the company. The company believes total long-term debt (including the current portion) is the financial measure calculated and presented in accordance with U.S. Generally Accepted Accounting Principles that is most directly comparable to Net Debt.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

University of Bridgeport and Goodwin University Revolutionize Regenerative Medicine Training Program Forming Strategic Alliance with Globally Recognized TulsiHub Institute
University of Bridgeport and Goodwin University Revolutionize Regenerative Medicine Training Program Forming Strategic Alliance with Globally Recognized TulsiHub Institute

Business Upturn

timean hour ago

  • Business Upturn

University of Bridgeport and Goodwin University Revolutionize Regenerative Medicine Training Program Forming Strategic Alliance with Globally Recognized TulsiHub Institute

BRIDGEPORT, CT, June 27, 2025 (GLOBE NEWSWIRE) — The two leading academic institutions have joined forces with TulsiHub Institute, the premier provider of advanced CE certified regenerative medicine certification programs, to transform medical education standards across regenerative medicine and cellular therapy disciplines. This innovative alliance positions both universities as pioneers in cutting-edge healthcare training while establishing new industry standards for professional medical certifications and continuing medical education in the rapidly expanding regenerative healthcare sector. Universities Pioneer Advanced Regenerative Medicine Education Partnership With the global regenerative medicine market expected to expand from $60 billion in 2023 to over $375 billion by 2031, this exponential growth creates significant demand for qualified practitioners capable of delivering advanced regenerative treatments including stem cell therapy, tissue engineering, and cellular therapy applications. The collaboration establishes both institutions as pioneers in advanced healthcare education, directly responding to the urgent need for comprehensive regenerative medicine training in the United States. This partnership addresses critical gaps in medical education across multiple regenerative medicine disciplines, including stem cell therapy, gene therapy, tissue engineering, cellular therapy, PRP (Platelet Rich Plasma) therapy, EBOO Therapy, Exosome therapy, Prolotherapy, and Shockwave therapy. 'It's a call to shape the very future of medicine,' remarked President Mark E. Scheinberg. 'We are excited to help forge a new generation of healthcare professionals who will redefine what's possible in patient care.' First-of-Its-Kind CE Certified Regenerative Medicine Training Program in the U.S. Through this strategic alliance, students gain access to the first intensive and comprehensive CE certified regenerative medicine training program of this caliber in the United States. The program features 12 specialized medical courses delivered through a unique 8-to-12-week intensive training methodology that combines theoretical medical knowledge with extensive practical training, ensuring certified healthcare professionals achieve clinical competency in cutting-edge regenerative medicine techniques. The evidence-based curriculum provides healthcare professionals with comprehensive on-site instruction under expert medical supervision with extensive hands-on experience. This approach ensures graduates possess both theoretical understanding and practical expertise in regenerative medicine applications, responding to urgent market demand from healthcare professionals seeking advanced training in regenerative therapies without geographic barriers. Students benefit from generous scholarships provided by TulsiHub Institute, along with access to seed funding opportunities of US$100,000 for establishing their own regenerative medicine clinics, and favorable lifetime discounts on medical consumables to support the ongoing success of their practices. This comprehensive support system addresses the practical implementation challenges newly certified practitioners face, providing essential financial resources to successfully transition from training to clinical application. 'This strategic collaboration establishes our institution as a leader in advanced healthcare education while reinforcing our dedication to equipping students and medical professionals with innovative training programs that address evolving industry requirements,' said University of Bridgeport President Danielle Wilken, Ed.D. Global Leader in Regenerative Medicine Certification TulsiHub Institute consortium maintains an exceptional 98% certification success rate while delivering internationally recognized credentials to medical professionals across 25 countries worldwide. As the gold standard in CE certified regenerative medicine certification, they have successfully certified over 500 healthcare professionals through comprehensive training programs. 'This partnership marks the first and only intensive and comprehensive CE certified regenerative medicine training program of this caliber available in the United States. We are responding to urgent market demand from healthcare professionals seeking advanced training in regenerative therapies without geographic barriers,' said Dr. Natasha Macleay, CEO of TulsiHub Institute. This institution also offers comprehensive certification programs equipping students with the latest advancements in longevity, preventive care, anti-aging protocols, in specialized areas like Dermatology, Orthopedics, Oncology Care, and Dentistry supported by a world-class faculty, advanced research facilities, and a dynamic community for collaboration. Academic Excellence and Leadership To ensure the highest standard in academic oversight, the program involves key University of Bridgeport leadership, including: Elena Cahill, JD, VP of Innovation, Strategy, and Advancement. Dr. Michael Ciolfi, Dean of the College of Health and Sciences; and Dr. James Lehman, Director of Health Sciences Postgraduate Education. The combined expertise of these individuals along with Raghav Goyal Co CEO of TulsiHub ensures the program maintains rigorous academic standards while addressing current industry requirements. Program Eligibility The program welcomes medical students, practicing physicians, nurses, chiropractors, and other healthcare professionals seeking specialized and CE certified regenerative medicine expertise. Eligibility encompasses MD, DO, DC, ND, DPM, PA, APRN degree holders, as well as RN, LPN, NP, CRNA, CNS, and CNM professionals. Visit to learn more about the courses and our partnership with the University of Bridgeport and Goodwin University. For media inquiries, please contact: Email: [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash

PrimeEnergy Resources Corporation Announces Change in Independent Registered Public Accounting Firm
PrimeEnergy Resources Corporation Announces Change in Independent Registered Public Accounting Firm

Business Upturn

timean hour ago

  • Business Upturn

PrimeEnergy Resources Corporation Announces Change in Independent Registered Public Accounting Firm

By GlobeNewswire Published on June 28, 2025, 02:50 IST HOUSTON, June 27, 2025 (GLOBE NEWSWIRE) — PrimeEnergy Resources Corporation (NASDAQ: PNRG, today announced that it has appointed Withum Smith+Brown, PC ('Withum') as the Company's independent registered public accounting firm, effective June 27, 2025. The decision to change auditors was recommended and approved by the Company's Audit Committee and the Board of Directors. PrimeEnergy Resources is an independent oil and natural gas company engaged in the acquisition, development, and production of hydrocarbons, primarily in Texas. The Company's common stock trades on the NASDAQ under the symbol PNRG. For investor inquiries, contact: Connie Ng – (713) 735-0000 ext. 6416 Forward-Looking Statements This Report contains forward-looking statements that are based on management's current expectations, estimates and projections. Words such as 'expects,' 'anticipates,' 'intends,' 'plans,' 'believes', 'projects' and 'estimates,' and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements constitute 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, and are subject to the safe harbors created thereby. These statements are not guarantees of future performance and involve risks and uncertainties and are based on a number of assumptions that could ultimately prove inaccurate and, therefore, there can be no assurance that they will prove to be accurate. Actual results and outcomes may vary materially from what is expressed or forecast in such statements due to various risks and uncertainties. These risks and uncertainties include, among other things, the possibility of drilling cost overruns and technical difficulties, volatility of oil and gas prices, competition, risks inherent in the Company's oil and gas operations, the inexact nature of interpretation of seismic and other geological and geophysical data, imprecision of reserve estimates, and the Company's ability to replace and expand oil and gas reserves. Accordingly, stockholders and potential investors are cautioned that certain events or circumstances could cause actual results to differ materially from those projected. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

INVESTOR DEADLINE: Robbins Geller Announces that Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
INVESTOR DEADLINE: Robbins Geller Announces that Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

Business Upturn

timean hour ago

  • Business Upturn

INVESTOR DEADLINE: Robbins Geller Announces that Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co. , No. 25-cv-05322 (D.N.J.) – seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon as well as certain of Organon's top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Organon class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. Lead plaintiff motions for the Organon class action lawsuit must be filed with the court no later than Tuesday, July 22, 2025. CASE ALLEGATIONS: Organon develops and delivers health solutions through prescription therapies and medical devices. The Organon class action lawsuit alleges that defendants throughout the class period made false and/or misleading statements and/or failed to disclose that: (i) defendants concealed material information pertaining to Organon's capital allocation priorities, particularly the future of the quarterly dividend payout; (ii) in truth, Organon's optimistic reports of the dividend payout as Organon's 'number one priority' were offset by Organon's newly implemented debt reduction strategy, thus, leading to a drastic decrease – over 70% – of the quarterly dividend; and (iii) Organon planned to prioritize debt reduction following Organon's acquisition of Dermavant Sciences Ltd. The Organon class action lawsuit further alleges that on May 1, 2025, Organon reported first quarter 2025 financial results and announced that management reset Organon's dividend payout from $0.28 to $0.02. On this news, the price of Organon stock fell more than 27%, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Organon securities during the class period to seek appointment as lead plaintiff in the Organon class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Organon class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Organon class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Organon class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store